Federal,state,and private-sector investments in vaccine purchases and immunization programs are lagging behind emerging opportunities to reduce the risks of vaccine-preventable disease.Although federal assistance to the states for immunization programs and data collection efforts rapidly expanded in the early part of the 1990s,significant cutbacks have occurred in the last 5 years that have reduced the size of state grant awards by more than 50 percent from their highest point.